SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?
Cardiovascular Research · 27.02.2024 · 120 (1) · 34-43
DOI: 10.1093/cvr/cvad191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 30.12.2023. Verfasst von Kathy O Lui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pathology, and Li Ka Shing Institute of Health Science, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 N…. Hauptthemen laut MEDLINE: COVID-19, Vascular Diseases. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 79 Literaturangaben.
Abstract (Originalsprache)
Clinical evidence reveals that manifestations of endothelial dysfunction are widely observed in COVID-19 and long-COVID patients. However, whether these detrimental effects are caused by direct infection of the endothelium or are indirectly mediated by systemic inflammation has been a matter of debate. It has been well acknowledged that endothelial cells (ECs) of the cardiovascular system ubiquitously express the SARS-CoV-2 entry receptor angiotensin-converting enzyme 2 (ACE2), yet accumulating evidence suggests that it is more predominantly expressed by pericytes and vascular smooth muscle cells of the mammalian blood vessel. Besides, replicative infection of ECs by SARS-CoV-2 has yet to be demonstrated both in vitro and in vivo. In this study, we review latest research on endothelial ACE2 expression in different vascular beds, and the heterogeneity in various EC subsets with differential ACE2 expression in response to SARS-CoV-2. We also discuss ACE2-independent alternative mechanisms underlying endothelial activation in COVID-19, and the clinical manifestations of SARS-CoV-2-induced endothelial dysfunction. Altogether, understanding ACE2-dependent and ACE2-independent mechanisms driving SARS-CoV-2-induced vascular dysfunction would shed light on strategies of more effective therapies targeting cardiovascular complications associated with COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Pathology, and Li Ka Shing Institute of Health Science, Prince of Wales Hospital, The Chinese University of Hong Kong, 30-32 Ngan Shing Street, Sha Tin, New Territories, 999077 Hong Kong, China.
- Institute for Cardiovascular Regeneration, and Faculty of Biological Sciences, Goethe University Frankfurt, Theodor Stern Kai 7, 60590 Frankfurt, Germany.
ORCID-Profile: Kathy O Lui, Stefanie Dimmeler
Zitieren
APA
Lui, K. O., Ma, Z., & Dimmeler, S. (2024). SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?. Cardiovascular Research, 120(1), 34-43. https://doi.org/10.1093/cvr/cvad191
Vancouver
Lui KO, Ma Z, Dimmeler S. SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?. Cardiovascular Research. 2024;120(1):34-43. doi:10.1093/cvr/cvad191
BibTeX
@article{Lui2024,
author = {Lui, Kathy O and Ma, Zhangjing and Dimmeler, Stefanie},
title = {SARS-CoV-2 induced vascular endothelial dysfunction: direct or indirect effects?},
journal = {Cardiovascular Research},
year = {2024},
volume = {120},
number = {1},
pages = {34--43},
doi = {10.1093/cvr/cvad191}
}
EUVIMED